Semiconductor Player STMicroelectronics Tops Q3 Expectations But Revises Annual Outlook: Details

STMicroelectronics NV (NYSE: STM) reported third-quarter FY23 revenue growth of 2.5% year-on-year to $4.43 billion, beating the 

STMicroelectronics NV (NYSE: STM) reported third-quarter FY23 revenue growth of 2.5% year-on-year to $4.43 billion, beating the consensus of $4.38 billion. EPS of $1.16 beat the consensus of $1.09.

Sales to OEMs increased by 2.1% Y/Y, and Distribution sales improved by 3.4% Y/Y.

Automotive and Discrete Group (ADG) revenue rose 29.6% Y/Y to $2.03 billion. Analog, MEMS, and Sensors Group (AMS) revenue changed by (28.3)% Y/Y to $990 million. Microcontrollers and Digital ICs Group (MDG) revenue grew 2.8% Y/Y to $1.41 billion. 

Margins: The gross margin remained stable at 47.6%. Improved product mix drove the margin. The operating margin declined by 140 bps to 28.0%.

STMicroelectronics generated $707 million in free cash flow and held $5.05 billion in cash and equivalents.

Outlook: STMicroelectronics sees Q4 revenue of $4.30 billion, a decrease of about 3% sequentially, plus or minus 350 bps (consensus $4.4 billion).

The company expects a Q4 gross margin of 46%, plus or minus 200 bps.

STMicroelectronics revised its FY23 revenues outlook to $17.3 billion, versus the prior $17.25 billion – $17.55 billion (consensus $17.36 billion) and a gross margin of 48.1%.

Price Action: STM shares traded higher by 3.49% at $40.35 premarket on the last check Thursday.

Total
0
Shares
Related Posts
Read More

EXCLUSIVE: Fifteen New F1 Hybrid Cannabis Strains To Hit Shelves In US For 4/20 Under New Partnership

California-based I Love Growing Marijuana (ILGM), announced on Tuesday an exclusive new partnership with cannabis genetics and breeding company, Phylos Bioscience, that brings 15 new F1 hybrid strains to home growers across legal markets nationwide. ILGM is launching half the collection of strains that are "crafted for potency, flavor, and diversity" on its website just in time for marijuana culture's high holiday on 4/20. In doing so, the company is leveraging Phylos Bioscience's cutting-edge technology and extensive genetic library, which Benzinga has learned exclusively. Ernst Rustenhoven, CEO of ILGM, commented on the new partnership. "ILGM caters to a customer base of novice and veteran home growers on the hunt for increasingly unique strains of superior genetics, and we have been seeking an innovative partner to help elevate and diversify our product offerings," Rustenhoven said. "In forging a relationship with Phylos, we are taking our seed catalog to the next level with a highly curated selection of sought-after F1 hybrid strains."

OGI

Read More

Earnings Preview For Liberty Global

Liberty Global (NASDAQ:LBTYA) is set to give its latest quarterly earnings report on Tuesday, 2022-11-01. Here's what investors need to know before the announcement. Analysts estimate that Liberty Global will report an earnings per share (EPS) of $-0.03.

LBTYA